These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 6406705)

  • 1. Peripheral vein complications in patients receiving amino acid/dextrose solutions.
    Massar EL; Daly JM; Copeland EM; Johnson DE; VonEshenbach AC; Johnston D; Rundell B; Dudrick SJ
    JPEN J Parenter Enteral Nutr; 1983; 7(2):159-62. PubMed ID: 6406705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral vein infusion of dextrose/amino acid solutions +/- 20% fat emulsion.
    Daly JM; Masser E; Hansen L; Canham JE
    JPEN J Parenter Enteral Nutr; 1985; 9(3):296-9. PubMed ID: 4009919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors determining peripheral vein tolerance to amino acid infusions.
    Gazitua R; Wilson K; Bistrian BR; Blackburn GL
    Arch Surg; 1979 Aug; 114(8):897-900. PubMed ID: 111645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the continuous administration of fat emulsion on the infiltration of intravenous lines in infants receiving peripheral parenteral nutrition solutions.
    Phelps SJ; Cochran EB
    JPEN J Parenter Enteral Nutr; 1989; 13(6):628-32. PubMed ID: 2614864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pH and osmolality on phlebitic potential of infusion solutions for peripheral parenteral nutrition.
    Kuwahara T; Asanami S; Tamura T; Kaneda S
    J Toxicol Sci; 1998 Feb; 23(1):77-85. PubMed ID: 9513923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells.
    Kuwahara T; Asanami S; Kubo S
    Nutrition; 1998 Jun; 14(6):496-501. PubMed ID: 9646289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maximum tolerated osmolarity for peripheral administration of parenteral nutrition in pediatric patients.
    Dugan S; Le J; Jew RK
    JPEN J Parenter Enteral Nutr; 2014 Sep; 38(7):847-51. PubMed ID: 23851423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-phase study of phlebitis in patients receiving peripheral intravenous hyperalimentation.
    Rypins EB; Johnson BH; Reder B; Sarfeh IJ; Shimoda K
    Am J Surg; 1990 Feb; 159(2):222-5. PubMed ID: 2105670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of phlebitis in peripheral parenteral nutrition: effect of the different nutrient solutions.
    Bayer-Berger M; Chioléro R; Freeman J; Hirschi B
    Clin Nutr; 1989 Aug; 8(4):181-6. PubMed ID: 16837286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral parenteral nutrition: effect of a standardized compounded mixture on infusion phlebitis.
    Nordenström J; Jeppsson B; Lovén L; Larsson J
    Br J Surg; 1991 Nov; 78(11):1391-4. PubMed ID: 1760712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total parenteral nutrition-associated cholestasis: acute studies in infant and adult rabbits.
    Zahavi I; Shaffer EA; Gall DG
    J Pediatr Gastroenterol Nutr; 1985 Aug; 4(4):622-7. PubMed ID: 3928864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of the aetiology of infusion phlebitis and line failure during peripheral parenteral nutrition.
    May J; Murchan P; MacFie J; Sedman P; Donat R; Palmer D; Mitchell CJ
    Br J Surg; 1996 Aug; 83(8):1091-4. PubMed ID: 8869311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of superficial phlebitis during peripheral parenteral nutrition.
    Makarewicz PA; Freeman JB; Fairfull-Smith R
    Am J Surg; 1986 Jan; 151(1):126-9. PubMed ID: 3080920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postinfusion phlebitis associated with a syringe system versus minibags.
    Rapp RP; Powers P; Tolbert V; Piecoro JJ; Record KE
    Clin Pharm; 1986 May; 5(5):408-11. PubMed ID: 3720211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incidence of phlebitis in patients with intestinal inflammatory disease undergoing peripheral parenteral nutrition].
    Romero Roger JA; Ibáñez GC; Correa Ballester M; Martí Bonmatí E
    Nutr Hosp; 1996; 11(1):63-5. PubMed ID: 8704020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppurative Candida phlebitis of a peripheral vein.
    Deitch EA; Marini JJ; Huseby JS
    J Trauma; 1980 Jul; 20(7):618-20. PubMed ID: 6771416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusion phlebitis associated with a programmable syringe-pump system versus gravity-feed minibottles.
    Baptista RJ; Driscoll DF; Gallagher JA; O'Keefe E; Dumas GJ; Hammer SM; Pacella PP
    Clin Pharm; 1987 Apr; 6(4):314-8. PubMed ID: 3665384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical study on the ratio of glucose/fat in peripheral parenteral nutrition and the usage of a midline catheter.
    Matsumoto M; Shirotani N; Kameoka S
    Surg Today; 1999; 29(10):1040-6. PubMed ID: 10554328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombogenicity of total parenteral nutrition solutions: I. Effect on induction of monocyte/macrophage procoagulant activity.
    Wakefield A; Cohen Z; Craig M; Connolley P; Jeejeebhoy KN; Silverman R; Levy GA
    Gastroenterology; 1989 Nov; 97(5):1210-9. PubMed ID: 2507384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, severity and risk factors of peripheral intravenous cannula-induced complications: An observational prospective study.
    Simin D; Milutinović D; Turkulov V; Brkić S
    J Clin Nurs; 2019 May; 28(9-10):1585-1599. PubMed ID: 30589945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.